Skip to main content
Premium Trial:

Request an Annual Quote

New York Clears Interleukin Genetics' Dental Test

NEW YORK (GenomeWeb News) – Interleukin Genetics has received clearance in the State of New York to offer its genetic test for risk of periodontal disease, the company said today.

The State of New York's Department of Health approved the firm's PST Genetic Test through its Clinical Laboratory Evaluation Program, which monitors the accuracy and reliability of the results of lab tests and specimens obtained within the state.

New York was the only state in the US to previously prohibit the firm from offering the test, which is marketed through a licensing agreement with Quest Diagnostics' subsidiary OralDNA Labs, to its residents.

The PST test identifies patients that have higher genetic risk for developing severe periodontal disease, which is the most common cause of tooth loss.

The firm said that the test is particularly useful for indicating which patients with early signs of periodontal disease, including gingivitis, and early to moderate periodontitis, are most likely to develop severe periodontitis and other complications.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.